Assuming effects is required, the following 69 results were found.
-
NGN-401https://cnke.org/articles/160
dendritic spine morphology and synaptic density. Safety Profile: Dose-escalation studies confirmed minimal off-target effects and no evidence of systemic toxicity. Clinical Trials Initial Phase I/II clinical trials have focused on safety, tolerability,...
- Type: Article
- Author: Editor
- Category: Home
-
Developmental Dysarthria in Syndromic Conditionshttps://cnke.org/articles/245
Developmental Dysarthria in Syndromic Conditions Causes: Often linked to structural brain anomalies such as perisylvian or perirolandic polymicrogyria, cerebellar anomalies, Joubert syndrome, and brainstem dysgenesis. Differential Diagnosis: Childhood...
- Type: Article
- Author: Editor CNKE
- Category: Articles
-
Idiopathic Intracranial Hypertensionhttps://cnke.org/articles/178
function (per IIHTT study). Topiramate: Dual role: Anti-migraine and appetite suppression. Caution for cognitive side effects and depression. Headache Management: Migrainous phenotype: Use migraine preventives that do not promote weight gain. Address...
- Type: Article
- Author: Editor
- Category: Home
-
Pyridoxal 5 Phosphate Dependent Epilepsyhttps://cnke.org/articles/31
PNPO deficiency (OMIM 6032870) is an autosomal recessive inborn error of metabolism that leads to a seizure disorder, presenting in the newborn period (neonatal epileptic encephalopathy) or early infancy, that can be treated with pyridoxal 5’-phosphate...
- Type: Article
- Author: Editor CNKE
- Category: Articles
-
Ataxias: Differential Diagnosishttps://cnke.org/articles/185
tumors to the cerebellum Abscess: Infectious collections in the cerebellum causing localized inflammation and pressure effects. Systemic Causes Liver Failure: Hepatocerebral Degeneration: Resulting from chronic liver dysfunction leading to toxic effects...
- Type: Article
- Author: Editor
- Category: Home
-
Genetic Epilepsy with Febrile Seizures Plus (GEFS+)https://cnke.org/articles/276
of GABAA receptor ion channels GABAA receptor channels inhibit signaling between neurons Involved in nerve signaling Effects of SCN1A Gene Mutations Variety of Effects on Sodium Channels Many mutations causing Dravet syndrome: reduce the number of...
- Type: Article
- Author: Editor
- Category: Home
-
ADCY5 Dyskinesiahttps://cnke.org/articles/213
quality, and fine motor skills. Safety Profile: Well-Tolerated; Safe for use, even in pediatric populations. Reported Side Effects:Hyperactivity in some patients. Dosage Example Regimen:Moderately strong cappuccino three times a day. Third dose no...
- Type: Article
- Author: Editor CNKE
- Category: Articles
-
How to edit this Knowledge Basehttps://cnke.org/about/182
Tha aim of CNKE.org is to develop a comprehensive continually updated trustworthy resource in child neurology. This can only be made possible through collaborative content authoring. There are several ways you can get involved in creating and...
- Type: Article
- Author: Editor
- Category: About
-
Why a Lecture Notes Style Knowledgebase on Child Neurology?https://cnke.org/about/180
The CNKE favours a lecture notes style approach for its articles for Clarity and Readability Inline citations can disrupt the flow of reading, especially for topics that require a step-by-step understanding of complex concepts. A lecture notes-style...
- Type: Article
- Author: Editor
- Category: About
-
The Normal EEG in Childrenhttps://cnke.org/articles/25
commonly seen using bipolar anteroposterior or coronal montages. Such apparent asymmetries may be due to field cancellation effects and should be verified using an ipsilateral ear reference run. However, even then, shifting asymmetries may normally be...
- Type: Article
- Author: Editor CNKE
- Category: Articles
-
PRRT2-Associated Disordershttps://cnke.org/articles/274
Short-term potentiation (STP) phenomena in response to short-duration, increasing frequency stimulation show opposite effects on excitatory (glutamatergic) and inhibitory (GABAergic) synapses. Increased facilitation in excitatory transmission and...
- Type: Article
- Author: Editor
- Category: Home
-
Paroxysmal Kinesigenic Dyskinesiashttps://cnke.org/articles/271
Historical Background The first known description of paroxysmal kinesigenic dyskinesias (PKD) was by Shuzo Kure (1892) detailing a Japanese man with PKD. Initial reports often regarded PKD as a form of reflex epilepsy. Currently it considered as one of...
- Type: Article
- Author: Editor
- Category: Home
-
Epilepsy in Rett Syndromehttps://cnke.org/articles/156
Introduction Prevalence: Epilepsy affects 50–70% of individuals with RTT, though earlier studies suggested rates as high as 90%. Variability in study designs and diagnostic criteria contribute to these differences. Epileptic and Nonepileptic Events:...
- Type: Article
- Author: Editor
- Category: Home
-
Sleep issues in Rett Syndromehttps://cnke.org/articles/158
Key points: Prevalence and Onset: Sleep problems affect 70–80% of individuals with RTT, with onset becoming evident between 18 months and 2 years. Sleep disturbances in RTT are significantly more common than in typically developing children. Sleep...
- Type: Article
- Author: Editor
- Category: Home
-
Narcolepsy-Cataplexyhttps://cnke.org/articles/241
for excessive daytime sleepiness, methylphenidate, and amphetamines, which may help some patients but have transitory effects. Antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) or imipramine, can benefit cataplexy, and sodium...
- Type: Article
- Author: Editor
- Category: Home
-
Familial (Autosomal Dominant) Focal Epilepsieshttps://cnke.org/articles/357
an EEG spike focus, indicating it as a marker for the syndrome. Prognosis: Development is usually normal. Management: Effects of new AEDs not directly evaluated. Carbamazepine and phenytoin appear to be effective. Autosomal Dominant Rolandic Epilepsy...
- Type: Article
- Author: Editor
- Category: Home
-
Rett Syndrome : Therapy prospectshttps://cnke.org/articles/159
due to challenges in design and heterogeneity in participants. Ongoing Trials: IGF-1 (Mecasermin): Positive neurobehavioral effects like reduced anxiety and apnea. Sarizotan: Focuses on improving respiratory irregularities. Trofinetide: Synthetic IGF-1...
- Type: Article
- Author: Editor
- Category: Home
-
Ion channel disordershttps://cnke.org/articles/231
Ion channel disorders, or channelopathies, are a group of conditions that involve dysfunctions in ion channels—integral membrane proteins regulating the flow of ions across cellular membranes. In skeletal muscle, these disorders variably produce...
- Type: Article
- Author: Editor CNKE
- Category: Articles
-
Trofinetidehttps://cnke.org/articles/161
common genetic cause of intellectual disability. Traumatic Brain Injury (TBI): Its neuroprotective and anti-inflammatory effects hold promise in reducing secondary injury cascades post-TBI. Clinical Trials and Efficacy Recent Phase III clinical trials...
- Type: Article
- Author: Editor
- Category: Home
-
Guillaume Duchenne (1806–1875)https://cnke.org/historical-vignettes/175
palsy impacting newborns. Duchenne's Disease (Tabes Dorsalis): His work contributed to understanding the neurodegenerative effects of syphilis on the spinal cord. Duchenne's Paralysis (Progressive Bulbar Palsy): His clinical observations helped...
- Type: Article
- Author: Biju Hameed
- Category: Historical Vignettes